Loading

Original Research Open Access

Network Pharmacology-Based Exploration of Cannabidiol (CBD) Therapeutic Mechanisms in Domestic Cats (Felis catus)

  • 1Stemcology, School of Veterinary Medicine, University College Dublin, Belfield, Dublin-04, Ireland
+ Affiliations - Affiliations

Corresponding Author

Arun HS Kumar, arun.kumar@ucd.ie

Received Date: May 27, 2026

Accepted Date: October 02, 2026

Abstract

Cannabidiol (CBD) is increasingly used in veterinary medicine due to its reported anti-inflammatory, analgesic, and anxiolytic properties. However, its molecular mechanisms in the domestic cat (Felis catus) remain poorly understood. This study applies a network pharmacology approach to elucidate the potential targets and biological pathways associated with CBD in cats. Putative CBD targets identified based on human protein databases were mapped to feline orthologs through homology matching. The resulting feline target set was used to construct a protein-protein interaction (PPI) network. Functional modules were identified using cluster and network enrichment analyses (molecular function, KEGG pathways, local cluster organization, and protein domain classification). In addition, molecular docking studies were conducted to evaluate CBD-target binding affinities. Network analysis identified 89 CBD-associated target clusters, of which 23 were functionally characterized, including four major clusters enriched in immune regulation, lipid metabolism, neuroactive signaling, and synaptic transmission. KEGG pathway analysis highlighted neuroactive ligand-receptor interaction and calcium signaling as key pathways. Local network analysis revealed enrichment in G protein-coupled receptor signaling, neuropeptide receptor activity, and lipid-derived signaling pathways. Molecular docking demonstrated strong binding affinities of CBD to key feline targets, including CNR1 (−8.7 kcal/mol), PDE5A (−8.6 kcal/mol), TYMS (−8.5 kcal/mol), NQO2 (−8.3 kcal/mol), STS (−8.3 kcal/mol), and CASR (−8.0 kcal/mol), suggesting involvement in endocannabinoid signaling, oxidative stress regulation, steroid metabolism, and calcium homeostasis. Our observations suggest that CBD exhibits a multi-target pharmacological profile in domestic cats, acting across interconnected immune, neurological, metabolic, and endocrine pathways. The integration of network pharmacology and molecular docking suggests that CBD functions as a pleiotropic modulator rather than a single-target agent. The observed interaction patterns are consistent with a favorable safety profile, supporting previous experimental evidence of tolerability in feline studies, including clinical applications in inflammatory conditions.

Keywords

Cannabidiol, Network pharmacology, Domestic cat, Molecular docking, Endocannabinoid system

Author Information X